Progressive Care Reports Record $32M Revenues, 70% Jump in Gross Profits, Leadership in Contactless Prescription Delivery Accelerating Momentum

NEXT STORY
FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics
PREV STORY
BioNTech Announces Full Year 2019 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Premiers résultats positifs pour le nirsevimab contre le VRS dans le cadre de l’essai MEDLEY de phase II/III

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection

Notice of Allowance received and, once granted, the new U.S. patent is expected to ...

author_avatar
NASDAQ Market News

Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed

author_avatar
NASDAQ Market News